IDEA: Factors to consider

IDEA: Factors to consider

moasc

2 months
2 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Afsaneh Barzi, MD of Keck School of Medicine discusses the factors to consider in the IDEA collaboration.

Up Next Autoplay
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Category: Colorectal Cancer
2 Views
WUSTL 2 weeks
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Category: Colorectal Cancer
17 Views
WUSTL 2 weeks
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
7 Views
Cancer-News 1 month
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
68 Views
Cancer-News 1 month
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
28 Views
Cancer-News 1 month
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
9 Views
Cleveland Clinic 2 months
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
3 Views
Cleveland Clinic 2 months
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
12 Views
Cleveland Clinic 2 months
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
2 Views
moasc 2 months